GuidelineJournal of thrombosis and haemostasis : JTH2015
Recommendations for standardization of laboratory testing for drug-induced immune thrombocytopenia: communication from the SSC of the ISTH.
Guideline in Journal of thrombosis and haemostasis : JTH, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.Multiple sclerosis (Houndmills, Basingstoke, England) · 2020Trial
- Timeline of heparin-induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay.International journal of laboratory hematology · 2019Trial
- Digging into the Cause of Drug-Induced Thrombocytopenia: A Case Report.Journal of the advanced practitioner in oncology · 2025Article
- Oxaliplatin-induced type II hypersensitivity in colorectal cancer: a cohort study on clinical presentation, diagnosis, and management.Frontiers in pharmacology · 2025Article
- Between a rock and a hard place: anticoagulation management for ECMO.Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2024Review
- Applications of Artificial Intelligence in Thrombocytopenia.Diagnostics (Basel, Switzerland) · 2023Review
- Acute drug-induced immune thrombocytopenia - A work of articaine.Transfusion · 2022Article
- Drug-Induced Immune Thrombocytopenia Toxicity Prediction Based on Machine Learning.Pharmaceutics · 2022Article
- SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia.Blood advances · 2022Article
- Severe vancomycin-induced thrombocytopenia in a patient with meningitis.BMJ case reports · 2021Article
- Rapid onset vancomycin-induced thrombocytopenia confirmed by vancomycin antibody test.BMJ case reports · 2021Article
- The EHA Research Roadmap: Platelet Disorders.HemaSphere · 2021Article
- Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia.Journal of clinical medicine · 2020Review
- Drug-associated thrombocytopenia.Hematology. American Society of Hematology. Education Program · 2018Review
- The European Hematology Association Roadmap for European Hematology Research: a consensus document.Haematologica · 2016Article
- Thrombocytopenia in an EGFR 19 Exon-Deficient Bilateral Diffuse LUAD with ARDS Treated with ECMO and Osimertinib: A Case Report.Case reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.